tetano
Editor, Senior Moderator
Cureus
. 2023 May 30;15(5):e39745.
doi: 10.7759/cureus.39745. eCollection 2023 May. The Discovery of an Intracardiac Thrombus Following a Mild COVID-19 Infection: A Case Report and Review of Literature
Jenish Bhandari[SUP] 1 [/SUP], Anas M Abbas[SUP] 2 [/SUP], John J Alfarone[SUP] 2 [/SUP], Syed Huda[SUP] 3 [/SUP], Niranjan Ojha[SUP] 3 [/SUP]
Affiliations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19) is a viral disease that predominantly affects the respiratory system, but extrapulmonary manifestations have been increasingly reported over the course of the pandemic. Common extrapulmonary manifestations include the gastrointestinal, cardiovascular, and neurological systems, such as diarrhea, rashes, loss of smell/taste, myalgia, acute kidney injury, cardiac arrhythmias, or heart failure. COVID-19 infection is associated with an increased risk of thromboembolic events, especially in the setting of severe disease. We present a case of a 42-year-old female who recently tested positive for COVID-19 infection and presented to the clinic with complaints of palpitations that started after her diagnosis. An electrocardiogram done in the clinic showed sinus rhythm, and the patient was placed on an event monitor, which showed no evidence of tachyarrhythmia. A transthoracic echocardiogram (TTE) done as part of the workup showed a large thrombus in the right ventricular outflow tract attached to the ventricular side of the pulmonic valve. The patient was started on a therapeutic dose of apixaban at 10 mg twice a day (BID) for seven days and 5 mg twice a day afterward.
Keywords: cardiology; cardiovascular; covid-19; echocardiography; infection; thrombus.
. 2023 May 30;15(5):e39745.
doi: 10.7759/cureus.39745. eCollection 2023 May. The Discovery of an Intracardiac Thrombus Following a Mild COVID-19 Infection: A Case Report and Review of Literature
Jenish Bhandari[SUP] 1 [/SUP], Anas M Abbas[SUP] 2 [/SUP], John J Alfarone[SUP] 2 [/SUP], Syed Huda[SUP] 3 [/SUP], Niranjan Ojha[SUP] 3 [/SUP]
Affiliations
- PMID: 37398759
- PMCID: PMC10310549
- DOI: 10.7759/cureus.39745
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19) is a viral disease that predominantly affects the respiratory system, but extrapulmonary manifestations have been increasingly reported over the course of the pandemic. Common extrapulmonary manifestations include the gastrointestinal, cardiovascular, and neurological systems, such as diarrhea, rashes, loss of smell/taste, myalgia, acute kidney injury, cardiac arrhythmias, or heart failure. COVID-19 infection is associated with an increased risk of thromboembolic events, especially in the setting of severe disease. We present a case of a 42-year-old female who recently tested positive for COVID-19 infection and presented to the clinic with complaints of palpitations that started after her diagnosis. An electrocardiogram done in the clinic showed sinus rhythm, and the patient was placed on an event monitor, which showed no evidence of tachyarrhythmia. A transthoracic echocardiogram (TTE) done as part of the workup showed a large thrombus in the right ventricular outflow tract attached to the ventricular side of the pulmonic valve. The patient was started on a therapeutic dose of apixaban at 10 mg twice a day (BID) for seven days and 5 mg twice a day afterward.
Keywords: cardiology; cardiovascular; covid-19; echocardiography; infection; thrombus.